Protective Effects of Nucleobinding-2 After Cerebral Ischemia Via Modulating Bcl-2/Bax Ratio and Reducing Glial Fibrillary Acid Protein Expression.

Apoptosis Astrogliosis Hippocampus Ischemia Nesfatin-1 Nucleobinding-2 (NUCB2)

Journal

Basic and clinical neuroscience
ISSN: 2008-126X
Titre abrégé: Basic Clin Neurosci
Pays: Iran
ID NLM: 101575211

Informations de publication

Date de publication:
Historique:
received: 31 05 2018
revised: 10 06 2019
accepted: 13 10 2018
entrez: 15 4 2020
pubmed: 15 4 2020
medline: 15 4 2020
Statut: ppublish

Résumé

Nucleobinding-2 (NUCB2) or nesfatin-1, a newly identified anorexigenic peptide, has antioxidant, anti-inflammatory, and anti-apoptotic properties. Brain ischemiareperfusion induces irreversible damages, especially in the hippocampus area. However, the therapeutic effects of NUCB2 have not been well investigated in cerebral ischemia. This study was designed for the first time to investigate the protective effects of NUCB2/Nesfatin-1 on the expression of apoptosis-related proteins and reactive astrogliosis level in the CA1 area of hippocampus in an experimental model of transient global cerebral ischemia. The male Wistar rats were randomly allocated into 4 groups (sham, NUCB2, ischemia-reperfusion, and ischemia-reperfusion+NUCB21) (n =7). The model of cerebral ischemia was prepared by common carotid arteries occlusion for 20 minutes. Nesfatin-1 (20 μg/kg) and saline (as a vehicle) were injected (intraperitoneally) at the beginning of the reperfusion period. The assessment of the protein expression levels was performed by immunofluorescence and immunohistochemical staining. NUCB2 significantly reduced the Bax and GFAP protein levels in the CA1 area after ischemia (P<0.05). Also, NUCB2 increased Bcl-2 protein level (P<0.05). NUCB2 exerted protective effects against ischemic injury by the inhibition of astrocytes activation as an inflammatory response and decreased neuronal cell apoptosis. The present study provides the possible neuroprotective view of nesfatin-1 in the treatment of ischemia injury model in rat hippocampus.

Identifiants

pubmed: 32284834
doi: 10.32598/bcn.10.5.451
pii: bcn-10-451
pmc: PMC7149952
doi:

Types de publication

Journal Article

Langues

eng

Pagination

451-459

Informations de copyright

Copyright© 2019 Iranian Neuroscience Society.

Déclaration de conflit d'intérêts

Conflict of interest The authors declared no conflict of interest.

Références

Future Neurol. 2014 Sep;9(5):541-551
pubmed: 25530721
Peptides. 2012 Jul;36(1):39-45
pubmed: 22561242
J Mol Neurosci. 2015 May;56(1):237-43
pubmed: 25603815
FEBS J. 2009 Jan;276(1):13-26
pubmed: 19087196
J Cereb Blood Flow Metab. 1997 Aug;17(8):815-32
pubmed: 9290580
J Cereb Blood Flow Metab. 2003 Feb;23(2):137-49
pubmed: 12571445
J Amino Acids. 2012;2012:967347
pubmed: 23316341
Nat Commun. 2017 Jun 22;8(1):28
pubmed: 28642575
Exp Neurobiol. 2016 Oct;25(5):241-251
pubmed: 27790058
J Immunol Res. 2015;2015:761820
pubmed: 26568964
Expert Rev Neurother. 2015;15(11):1271-84
pubmed: 26469760
Stroke. 2008 Mar;39(3):935-42
pubmed: 18258827
Neurol Res. 2016 Mar;38(3):210-9
pubmed: 26352929
ISRN Neurol. 2014 Jan 21;2014:515716
pubmed: 24579051
J Neuroinflammation. 2009 Sep 24;6:27
pubmed: 19778412
Sci Rep. 2017 Jul 19;7(1):5800
pubmed: 28724924
Ren Fail. 2015 Jun;37(5):882-9
pubmed: 25707521
J Physiol Sci. 2015 Sep;65(5):435-43
pubmed: 26012958
Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):E396-E405
pubmed: 27994144
J Cell Biol. 2002 Aug 5;158(3):507-17
pubmed: 12147675
Neural Regen Res. 2015 Aug;10(8):1245-50
pubmed: 26487851
Neurosurgery. 2011 Jun;68(6):1699-708; discussion 1708
pubmed: 21336215
Neuropharmacology. 2008 Sep;55(3):310-8
pubmed: 18308346
Oncotarget. 2017 Aug 14;8(43):74607-74622
pubmed: 29088811
Stroke. 2008 Aug;39(8):2362-9
pubmed: 18583563
J Surg Res. 2015 Jan;193(1):111-8
pubmed: 25082746
Int J Clin Exp Med. 2015 Mar 15;8(3):3318-24
pubmed: 26064221
Nat Rev Neurosci. 2015 May;16(5):249-63
pubmed: 25891508
Oxid Med Cell Longev. 2017;2017:5058609
pubmed: 28785376
Neuropeptides. 2015 Feb;49:63-8
pubmed: 25617953
Basic Clin Neurosci. 2016 Jan;7(1):21-9
pubmed: 27303596
J Neurosurg. 2015 Jul;123(1):243-53
pubmed: 25723306

Auteurs

Sohaila Erfani (S)

Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.

Ali Moghimi (A)

Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.

Nahid Aboutaleb (N)

Department of Physiology, Faculty of Medicine, Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran.

Mehdi Khaksari (M)

Addiction Research Center, Shahroud University of Medical Sciences, Shahroud, Iran.

Classifications MeSH